🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and tolerability of MK-36...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02256553
The purpose of this study was to determine the maximum tolerated dose of AL...
Status
Completed
Location
Alcon Call Center for Trial Locations
Start Date
2011-10
Trial ID
NCT01454505
Treatments Being Tested
Ragweed is the primary cause of autumn allergies. The ragweed season begins...
Status
Completed
Location
Cetero Research
Start Date
2011-10
Trial ID
NCT01448603
Treatments Being Tested
This study will test the effectiveness of an investigational treatment for ...
Status
Terminated
Location
Johns Hopkins University
Start Date
2006-04
Trial ID
NCT00318747
Treatments Being Tested
The purpose of this study is to evaluate the onset of action of fluticasone...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01076439
Treatments Being Tested
The goal of this clinical trail is to learn about how asthma influences bra...
Status
Recruiting
Location
University of Wisconsin Madison
Start Date
2019-12-17
Trial ID
NCT04307667
Treatments Being Tested
The ragweed Ambrosia artemisiifolia is spreading in northern Europe due to ...
Status
Completed
Location
Fraunhofer Institute for Toxicology and Experimental Medicine
Start Date
2022-09-01
Trial ID
NCT05346718
Treatments Being Tested
The purpose of this study is to examine the safety and efficacy of bepotast...
Status
Completed
Location
ISTA Pharmaceuticals, Inc.
Start Date
2010-05
Trial ID
NCT01222299
This study will evaluate the efficacy and safety of ragweed sublingual tabl...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00770315
Treatments Being Tested
The purpose of this study is to evaluate two investigational ophthalmic sol...
Status
Completed
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02079649